Hepatitis C Clinical Trial
Official title:
A Patient-Centered Intervention to Increase Screening of Hepatitis B and C Among Asian Americans
Liver cancer and hepatitis B are health disparities for Asian Americans, and hepatitis C is a
rising problem. Little is known about how to improve the quality of health care Asian
Americans receive for viral hepatitis. Technology, specifically mobile applications, can
provide a flexible and efficient way to address these challenges. This project seeks to
develop, implement, and test an intervention to increase hepatitis B and C screening for
Asian Americans in 2 healthcare systems in San Francisco.
The research team will develop, implement, and evaluate the efficacy of an interactive,
patient- centered mobile app for use on a tablet computer to increase hepatitis B and C
screening among unscreened Asian Americans age 18 and older. The team will use their
experience in health promotion to develop the intervention by working with patients,
community leaders and advocates, clinical staff, healthcare providers, and healthcare system
administrators from a county safety net system and an academic primary care practice in the
San Francisco Bay Area. The mobile application will include video clips with a physician
(Video Doctor) addressing patient concerns regarding hepatitis B and C screening in the
patient's preferred language, English, Chinese, or Vietnamese. A patient who has not been
screened for hepatitis B will answer questions about his or her characteristics and
preferences using the mobile application. The mobile application will then show 30-60 seconds
video clips with messages that address the patient's responses related to hepatitis B
screening and that are delivered by an actor playing a physician. Those who are born between
1945 and 1965 also receive messages about hepatitis C screening. At the end, the tablet
computer will generate a provider alert to let the treating provider know what the patient's
preferences are regarding testing for viral hepatitis.
Once developed, the intervention will then be used in combination with a physician panel
notification and tested against physician panel notification only in a randomized controlled
trial to see which approach is better in increasing the rate of hepatitis B and C screening.
The team will also work with the 2 healthcare system to ensure that the interventions will be
practical and easily adopted once the study is over. The findings of this project will
greatly expand understanding about how to use technology- based interventions to improve
quality of healthcare in diverse patient populations.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT03686722 -
Effect of Co-administration of Metformin and Daclatasvir on the Pharmacokinetis and Pharmacodynamics of Metformin
|
Phase 1 | |
| Recruiting |
NCT04510246 -
Link Hepatitis C Notifications to Treatment in Tasmania
|
N/A | |
| Completed |
NCT03413696 -
Effects of Health Literacy and HCV Knowledge on HCV Treatment Willingness in HIV-coinfected Patients
|
||
| Completed |
NCT03109457 -
Hepatitis C Virus Detection in Oral Squamous Cell Carcinoma
|
||
| Completed |
NCT03118674 -
Harvoni Treatment Porphyria Cutanea Tarda
|
Phase 2 | |
| Completed |
NCT01458054 -
Effect of Omeprazole and Ritonavir on GSK2336805 Pharmacokinetics in Healthy Adults
|
Phase 1 | |
| Completed |
NCT03740230 -
An Observational Study of Maviret (Glecaprevir/Pibrentasvir) for Korean Chronic Hepatitis C Genotypes 1 to 6 Patients According to the Standard for Re-examination of New Drugs
|
||
| Completed |
NCT03426787 -
Helping Empower Liver and Kidney Patients
|
N/A | |
| Completed |
NCT03627299 -
Renal Transplants in Hepatitis C Negative Recipients With Nucleic Acid Positive Donors
|
Phase 4 | |
| Completed |
NCT00006301 -
Immune Response to Hepatitis C Virus
|
||
| Active, not recruiting |
NCT03949764 -
The Kentucky Viral Hepatitis Treatment Study
|
Phase 4 | |
| Completed |
NCT03365635 -
Administration of Zepatier (Grazoprevir Plus Elbasvir) in Chronic Hemodialysis (HD) Patients With Hepatitis C
|
Phase 4 | |
| Recruiting |
NCT04405024 -
Pilot Study on the Feasibility of Systematic Hepatitis C Screening of Hospitalized Patients
|
N/A | |
| Completed |
NCT04525690 -
Improving Inpatient Screening for Hepatitis C
|
N/A | |
| Completed |
NCT04033887 -
Evaluation Study of RDTs Detecting Antibodies Against HCV
|
||
| Withdrawn |
NCT04546802 -
HepATocellular Cancer Hcv Therapy Study
|
Phase 3 | |
| Active, not recruiting |
NCT02961426 -
Strategic Transformation of the Market of HCV Treatments
|
Phase 2/Phase 3 | |
| Completed |
NCT03186313 -
A Study to Evaluate the Safety and Efficacy of the Combined Single Dose of Dactavira Plus Or Dactavira in Egyptian Adults With Chronic Genotype 4 HCV Infection
|
Phase 3 | |
| Completed |
NCT02683005 -
Study of Hepatitis C Treatment During Pregnancy
|
Phase 1 | |
| Completed |
NCT02705534 -
Sofosbuvir, Ledipasvir, Ribavirin for Hepatitis C Cirrhotics, Genotype 1
|
Phase 3 |